Teva Pharmaceutical Industries Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $16.38B | $1.85B |
| FY2009 | $4.06B | $19.22B | $2.00B |
| FY2010 | $4.80B | $21.95B | $1.25B |
| FY2011 | $11.39B | $22.20B | $1.10B |
| FY2012 | $14.14B | $22.77B | $2.88B |
| FY2013 | $11.20B | $22.57B | $1.04B |
| FY2014 | $8.57B | $23.31B | $2.23B |
| FY2015 | $8.36B | $29.77B | $6.95B |
| FY2016 | $32.52B | $29.93B | $6.95B |
| FY2017 | $28.83B | $17.36B | $963.0M |
| FY2018 | — | $14.71B | $1.78B |
| FY2019 | — | $13.97B | $1.98B |
| FY2020 | — | $10.03B | $2.18B |
| FY2021 | — | $10.28B | $2.17B |
| FY2022 | — | $9.81B | $2.80B |
| FY2023 | — | $8.50B | $3.23B |
| FY2024 | — | $5.37B | $3.30B |
| FY2025 | — | $7.91B | $3.56B |